{"trigger": ["Mononuclear leukocyte <extra_id_0> glucocorticoid receptor <extra_id_2> Protein <extra_id_1> binding characteristics and down-regulation in major depression .", ""], "relation": []}
{"trigger": ["Some patients with major depressive disorder ( MDD ) have elevated plasma cortisol concentrations and show failure to suppress cortisol secretion upon administration of dexamethasone ( DEX ) , yet they do not have Cushingoid features .", ""], "relation": []}
{"trigger": ["To study whether this represents glucocorticoid ( GC ) resistance , [ 3H ] - DEX-binding assays were used to measure , in vitro , the GC receptor affinity ( 1 / Kd ) and number ( Bmax ) in mononuclear leukocytes of 11 MDD patients and 15 control subjects .", ""], "relation": []}
{"trigger": ["No receptor abnormalities were detected in the MDD group ; thus any cellular defect leading to a lack of responsiveness to GC in the MDD patients , if present , probably lies beyond the initial receptor binding .", ""], "relation": []}
{"trigger": ["DEX ( 1.0 mg orally ) was administered to study in vivo GC receptor down-regulation .", ""], "relation": []}
{"trigger": ["Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .", ""], "relation": []}
{"trigger": ["By paired t-test , Bmax decreased significantly in the control group but not in the depressed group .", ""], "relation": []}
{"trigger": ["Receptor number on the control day did not correlate significantly with the degree of receptor down-regulation , severity of depression or cortisol concentrations across all the subjects .", ""], "relation": []}
{"trigger": ["These results do not lend support to previous reports suggesting that GC resistance in MDD results from a GC receptor - binding abnormality , and they emphasize the importance of considering receptor studies in the context of GC - mediated cell processes in order to identify the exact cellular defect ( s ) leading to GC resistance .", ""], "relation": []}
